REPRO-MED Systems (KRMD) Gets a Buy from Lake Street
Lake Street analyst Frank Takkinen reiterated a Buy rating on REPRO-MED Systems (KRMD – Research Report) today and set a price target of $6.00.
Hosted on MSN4d
Piper Sandler Downgrades KORU Medical Systems (KRMD)
Fintel reports that on February 14, 2025, Piper Sandler downgraded their outlook for KORU Medical Systems (NasdaqCM:KRMD) ...
Koru Medical downgraded to Neutral from Overweight at Piper Sandler
Piper Sandler analyst Jason Bednar downgraded Koru Medical (KRMD) to Neutral from Overweight with an unchanged price target of $4.50. The ...
Business Wire19d
KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the ...
ETF Daily News3d
KORU Medical Systems’ (KRMD) “Neutral” Rating Reaffirmed at Piper Sandler
Shares of NASDAQ:KRMD opened at $4.37 on Friday. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $200.31 ...
KORU Medical Systems Has A Long Runway
The SCIg market is growing rapidly, with KORU Medical Systems outperforming competitors by capturing market share. Read why I ...
CNN5d
KORU Medical Systems, Inc.
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate ...
Seeking Alpha18d
KRMD KORU Medical Systems, Inc.
KORU Medical Systems, Inc. (KRMD) stock price is 4.39 and KORU Medical Systems, Inc. (KRMD) 10-day simple moving average is 4.20. KORU Medical Systems, Inc. (KRMD) stock price is 4.39 and KORU ...
Wall Street Journal18d
KORU Medical Systems Inc.
1 Day KRMD 3.05% DJIA -0.75% Russell 2K -0.86% Health Care/Life Sciences -0.88% ...